NEOPLASMS BY SITE

Clinical trials for NEOPLASMS BY SITE explained in plain language.

Never miss a new study

Get alerted when new NEOPLASMS BY SITE trials appear

Sign up with your email to follow new studies for NEOPLASMS BY SITE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1 Not yet finished but already full! 1

Could existing melanoma drugs work for other rare cancers? new trial aims to find out.

Disease control Not yet recruiting

This trial tests if a combination of two drugs (dabrafenib and trametinib) can shrink or control rare cancers that have a specific gene change called BRAF V600. These drugs are already approved for melanoma and lung cancer with this mutation. About 30 adults and children with var…

Matched conditions: NEOPLASMS BY SITE

Phase: PHASE2, PHASE3 • Sponsor: Cancer Research UK • Aim: Disease control

Last updated Apr 28, 2026 23:50 UTC

NEOPLASMS BY SITE

Get alerted when new NEOPLASMS BY SITE trials appear

Could existing melanoma drugs work for other rare cancers? new trial aims to find out.